Anne Verhagen

Title: Anne Verhagen: Innovator in Blood Coagulation Research

Introduction

Anne Verhagen is a prominent inventor based in Northcote, Australia. She has made significant contributions to the field of blood coagulation research. Her work focuses on reducing the immunogenicity of Factor VIII, which is crucial for patients suffering from blood coagulation disorders.

Latest Patents

Anne Verhagen holds a patent for her invention titled "Modulation of FVIII immunogenicity by truncated VWF." This invention relates to a recombinant polypeptide that comprises a truncated von Willebrand Factor (VWF) capable of binding to blood coagulation Factor VIII (FVIII). The goal of this invention is to reduce the immunogenicity of FVIII when co-administered with a blood coagulation Factor VIII protein to subjects suffering from blood coagulation disorders. The invention also includes pharmaceutical compositions and kits for this use. She has 1 patent to her name.

Career Highlights

Anne Verhagen is associated with Csl Behring Lengnau AG, where she continues to advance her research in blood coagulation. Her innovative work has the potential to improve treatment options for patients with coagulation disorders.

Collaborations

Anne collaborates with notable colleagues, including Sabine Pestel and Thomas Weimer, who contribute to her research efforts and innovations.

Conclusion

Anne Verhagen is a dedicated inventor whose work in blood coagulation research is paving the way for new therapeutic approaches. Her contributions are vital for enhancing patient care in this critical area of medicine.